Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Cost of Revenue

$305.20M

Quarterly · Period ending: Jun 30, 2026 · USD

BIO Cost of Revenue

Latest reported$305.20Mperiod endingJun 30, 2026

BIO Quarterly Cost of Revenue ($0.00 → $305.20M)

Quarterly cost of revenue

High-resolution chart · PNG

BIO cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Cost of Revenue — Quarterly (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2026	305,200,000
Mar 31, 2026	282,700,000
Dec 31, 2025	348,000,000
Sep 30, 2025	309,600,000
Jun 30, 2025	306,300,000
Mar 31, 2025	279,400,000
Dec 31, 2024	325,563,000
Sep 30, 2024	293,826,000
Jun 30, 2024	282,757,000
Mar 31, 2024	284,354,000
Dec 31, 2023	315,284,000
Sep 30, 2023	296,441,000
Jun 30, 2023	318,627,000
Mar 31, 2023	314,427,000
Dec 31, 2022	333,191,000
Sep 30, 2022	307,008,000
Jun 30, 2022	295,118,000
Mar 31, 2022	297,427,000
Dec 31, 2021	331,768,000
Sep 30, 2021	309,614,000
Jun 30, 2021	314,333,000
Mar 31, 2021	326,169,000
Dec 31, 2020	329,684,000
Sep 30, 2020	279,952,000
Jun 30, 2020	243,892,000
Mar 31, 2020	254,276,000
Dec 31, 2019	293,989,000
Sep 30, 2019	253,607,000
Jun 30, 2019	264,850,000
Mar 31, 2019	242,217,000
Dec 31, 2018	283,765,000
Sep 30, 2018	258,422,000
Jun 30, 2018	274,244,000
Mar 31, 2018	249,316,000
Dec 31, 2017	280,840,000
Sep 30, 2017	230,483,000
Jun 30, 2017	231,367,000
Mar 31, 2017	230,064,000
Dec 31, 2016	257,096,000
Sep 30, 2016	229,276,000
Jun 30, 2016	236,545,000
Mar 31, 2016	207,168,000
Dec 31, 2015	262,042,000
Sep 30, 2015	206,509,000
Jun 30, 2015	226,505,000
Mar 31, 2015	202,715,000
Dec 31, 2014	280,814,000
Sep 30, 2014	242,068,000
Jun 30, 2014	239,590,000
Mar 31, 2014	234,055,000
Dec 31, 2013	279,886,000
Sep 30, 2013	220,850,000
Jun 30, 2013	225,220,000
Mar 31, 2013	228,260,000
Dec 31, 2012	252,786,000
Sep 30, 2012	225,187,000
Jun 30, 2012	222,522,000
Mar 31, 2012	207,695,000
Dec 31, 2011	239,272,000
Sep 30, 2011	220,338,000
Jun 30, 2011	228,520,000
Mar 31, 2011	207,510,000
Dec 31, 2010	233,997,000
Sep 30, 2010	205,172,000
Jun 30, 2010	199,354,000
Mar 31, 2010	197,107,000
Dec 31, 2009	226,604,000
Sep 30, 2009	200,545,000
Jun 30, 2009	185,221,000
Mar 31, 2009	172,031,000
Dec 31, 2008	201,289,000
Sep 30, 2008	201,300,000
Jun 30, 2008	203,940,000
Mar 31, 2008	195,314,000
Dec 31, 2007	226,055,000
Sep 30, 2007	151,385,000
Jun 30, 2007	149,123,000
Mar 31, 2007	143,127,000
Dec 31, 2006	157,524,000
Sep 30, 2006	137,975,000
Jun 30, 2006	133,085,000
Mar 31, 2006	132,810,000
Dec 31, 2005	144,662,000
Sep 30, 2005	126,413,000
Jun 30, 2005	130,659,000
Mar 31, 2005	132,765,000
Dec 31, 2004	139,533,000
Sep 30, 2004	116,036,000
Jun 30, 2004	110,885,000
Mar 31, 2004	115,866,000
Dec 31, 2003	117,350,000
Sep 30, 2003	110,281,000
Jun 30, 2003	107,103,000
Mar 31, 2003	103,256,000
Dec 31, 2002	106,155,000
Sep 30, 2002	95,852,000
Jun 30, 2002	92,386,000
Mar 31, 2002	88,842,000
Dec 31, 2001	99,482,000
Sep 30, 2001	79,918,000